272 related articles for article (PubMed ID: 15668900)
1. Anaplastic meningioma versus meningeal hemangiopericytoma: immunohistochemical and genetic markers.
Rajaram V; Brat DJ; Perry A
Hum Pathol; 2004 Nov; 35(11):1413-8. PubMed ID: 15668900
[TBL] [Abstract][Full Text] [Related]
2. Differential Diagnosis of Meningeal SFT-HPC and Meningioma: Which Immunohistochemical Markers Should Be Used?
Macagno N; Figarella-Branger D; Mokthari K; Metellus P; Jouvet A; Vasiljevic A; Loundou A; Bouvier C
Am J Surg Pathol; 2016 Feb; 40(2):270-8. PubMed ID: 26448189
[TBL] [Abstract][Full Text] [Related]
3. [Contribution of immunohistochemistry and electron microscopy for the diagnosis of meningeal hemangiopericytomas. 15 case reports].
Bouvier-Labit C; Liprandi A; Piercecchi MD; Hosseini H; Hénin D; Figarella-Branger D
Ann Pathol; 2000 Oct; 20(5):492-8. PubMed ID: 11084416
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical staining for claudin-1 can help distinguish meningiomas from histologic mimics.
Hahn HP; Bundock EA; Hornick JL
Am J Clin Pathol; 2006 Feb; 125(2):203-8. PubMed ID: 16393681
[TBL] [Abstract][Full Text] [Related]
5. Expression of E-cadherin and catenins in meningioma: ubiquitous expression and its irrelevance to malignancy.
Shimada S; Ishizawa K; Hirose T
Pathol Int; 2005 Jan; 55(1):1-7. PubMed ID: 15660696
[TBL] [Abstract][Full Text] [Related]
6. Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization.
Ishino S; Hashimoto N; Fushiki S; Date K; Mori T; Fujimoto M; Nakagawa Y; Ueda S; Abe T; Inazawa J
Cancer; 1998 Jul; 83(2):360-6. PubMed ID: 9669820
[TBL] [Abstract][Full Text] [Related]
7. Meningeal Hemangiopericytomas and Meningomas: a Comparative Immunohistochemical and Genetic Study.
Trabelsi S; Mama N; Chourabi M; Mastouri MH; Ladib M; Popov S; Burford A; Mokni M; Tlili K; Krifa H; Jones C; Yacoubi MT; Saad A; Brahim DH
Asian Pac J Cancer Prev; 2015; 16(16):6871-6. PubMed ID: 26514459
[TBL] [Abstract][Full Text] [Related]
8. A clinicopathological and immunohistochemical study of central nervous system hemangiopericytomas.
Sundaram C; Uppin SG; Uppin MS; Rekha JS; Panigrahi MK; Purohit AK; Rammurti S
J Clin Neurosci; 2010 Apr; 17(4):469-72. PubMed ID: 20167500
[TBL] [Abstract][Full Text] [Related]
9. Intracranial anaplastic solitary fibrous tumor/hemangiopericytoma: immunohistochemical markers for definitive diagnosis.
Yamashita D; Suehiro S; Kohno S; Ohue S; Nakamura Y; Kouno D; Ohtsuka Y; Nishikawa M; Matsumoto S; Bernstock JD; Harada S; Mizuno Y; Kitazawa R; Ohnishi T; Kunieda T
Neurosurg Rev; 2021 Jun; 44(3):1591-1600. PubMed ID: 32671693
[TBL] [Abstract][Full Text] [Related]
10. Hemangiopericytoma of the meninges: a clinicopathologic and immunohistochemical study.
Iwaki T; Fukui M; Takeshita I; Tsuneyoshi M; Tateishi J
Clin Neuropathol; 1988; 7(3):93-9. PubMed ID: 3060290
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of NF2 gene deletion in pediatric meningiomas using chromogenic in situ hybridization.
Begnami MD; Rushing EJ; Santi M; Quezado M
Int J Surg Pathol; 2007 Apr; 15(2):110-5. PubMed ID: 17478763
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications.
Cai DX; Banerjee R; Scheithauer BW; Lohse CM; Kleinschmidt-Demasters BK; Perry A
J Neuropathol Exp Neurol; 2001 Jun; 60(6):628-36. PubMed ID: 11398839
[TBL] [Abstract][Full Text] [Related]
13. Factor XIIIa immunoreactivity in primary and secondary tumours of the meninges.
Gottschalk J; Jautzke G; Märzheuser-Brands S; Cervos-Navarro J
Zentralbl Pathol; 1993 Nov; 139(4-5):343-9. PubMed ID: 7907501
[TBL] [Abstract][Full Text] [Related]
14. A reappraisal of hemangiopericytoma of bone; analysis of cases reclassified as synovial sarcoma and solitary fibrous tumor of bone.
Verbeke SL; Fletcher CD; Alberghini M; Daugaard S; Flanagan AM; Parratt T; Kroon HM; Hogendoorn PC; Bovée JV
Am J Surg Pathol; 2010 Jun; 34(6):777-83. PubMed ID: 20421780
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fluorescence in situ hybridization study.
Loussouarn D; Brunon J; Avet-Loiseau H; Campone M; Mosnier JF
Hum Pathol; 2006 Apr; 37(4):415-21. PubMed ID: 16564915
[TBL] [Abstract][Full Text] [Related]
16. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin D synthase (beta-trace) in meningeal hemangiopericytoma.
Kawashima M; Suzuki SO; Yamashima T; Fukui M; Iwaki T
Mod Pathol; 2001 Mar; 14(3):197-201. PubMed ID: 11266526
[TBL] [Abstract][Full Text] [Related]
18. The immunophenotypic spectrum of meningeal hemangiopericytoma: a comparison with fibrous meningioma and solitary fibrous tumor of meninges.
Perry A; Scheithauer BW; Nascimento AG
Am J Surg Pathol; 1997 Nov; 21(11):1354-60. PubMed ID: 9351573
[TBL] [Abstract][Full Text] [Related]
19. ALDH1 is an immunohistochemical diagnostic marker for solitary fibrous tumours and haemangiopericytomas of the meninges emerging from gene profiling study.
Bouvier C; Bertucci F; Métellus P; Finetti P; Maues de Paula A; Forest F; Mokhtari K; Miquel C; Birnbaum D; Vasiljevic A; Jouvet A; Coindre JM; Loundou A; Figarella-Branger D
Acta Neuropathol Commun; 2013 May; 1():10. PubMed ID: 24252471
[TBL] [Abstract][Full Text] [Related]
20. Inactivation patterns of NF2 and DAL-1/4.1B (EPB41L3) in sporadic meningioma.
Nunes F; Shen Y; Niida Y; Beauchamp R; Stemmer-Rachamimov AO; Ramesh V; Gusella J; MacCollin M
Cancer Genet Cytogenet; 2005 Oct; 162(2):135-9. PubMed ID: 16213361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
